Market Price

65.77 

0.00 0.0%

as of Feb 20 '19

52 Week Range:

50.71 66.35


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

Orbotech Ltd. provides yield-enhancing and process-enabling solutions for the manufacture of printed circuit boards (PCBs), flat panel displays (FPDs), semiconductor devices (SDs), and other electronic components in China, Taiwan, North America, Europe, Japan, Korea, and internationally. It operates through three segments: Production Solutions for the Electronics Industry, Solar Energy, and Recognition Software. The company designs, develops, manufactures, markets, and services direct imaging, automated optical inspection (AOI), automated optical shaping, via formation laser drilling tools, additive printing solutions, and other production systems used in the manufacture of PCBs; AOI, test, repair, and process monitoring systems for use in the manufacture of FPDs; and etch, physical vapor deposition, chemical vapor deposition, and molecular vapor deposition equipment used in the manufacture of SDs, such as micro-electro-mechanical systems, advanced semiconductor packaging, power and radio frequency devices, and high brightness light emitting diode devices. It is also involved in the research, development, and marketing of products for the deposition of thin film coating of various materials on crystalline silicon photovoltaic wafers for solar energy panels. In addition, the company develops and markets check processing and healthcare payments automation solutions to banks, financial, and other payment processing institutions and healthcare providers through system integrators and solution providers. The company was formerly known as Optrotech Ltd. and changed its name to Orbotech Ltd. as a result of its merger with Orbot Systems Ltd. in October 1992. Orbotech Ltd. was founded in 1981 and is headquartered in Yavne, Israel.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Dec '07 Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17
Equity (BVPS) 13.24
9.13
8.94
9.91
11.19
10.30
10.96
11.56
12.76
15.17
17.53
growth rate -31.0% -2.1% 10.9% 12.9% -8.0% 6.4% 5.5% 10.4% 18.9% 15.6%
Earnings BIT 4.45
-140.81
-20.17
50.40
53.51
-38.50
49.00
49.64
88.23
113.50
131.52
growth rate -100.0% 0.0% 100.0% 6.2% -100.0% 100.0% 1.3% 77.7% 28.7% 15.9%
Avg.PE 400.00
-4.30
-16.10
10.89
8.83
-9.00
14.71
20.17
18.18
17.56
20.58
growth rate -100.0% 0.0% 100.0% -18.9% -100.0% 100.0% 37.1% -9.9% -3.4% 17.2%
ROA 0.26
-22.40
-3.21
5.53
6.88
-6.51
6.20
4.24
5.46
7.39
11.00
growth rate -100.0% 0.0% 100.0% 24.4% -100.0% 100.0% -31.6% 28.8% 35.4% 48.9%
ROE 0.34
-36.03
-6.40
10.37
11.32
-9.74
8.75
7.33
10.65
12.01
15.92
growth rate -100.0% 0.0% 100.0% 9.2% -100.0% 100.0% -16.2% 45.3% 12.8% 32.6%
ROIC -0.98
-25.26
-1.71
8.42
9.99
-8.67
8.80
5.30
8.84
10.38
14.66
growth rate 0.0% 0.0% 100.0% 18.7% -100.0% 100.0% -39.8% 66.8% 17.4% 41.2%
Cur. Ratio 4.93
1.60
3.52
3.53
4.26
3.49
4.33
3.25
3.24
3.17
3.37
growth rate -67.6% 120.0% 0.3% 20.7% -18.1% 24.1% -24.9% -0.3% -2.2% 6.3%
Quick Ratio 3.95
1.10
2.69
2.60
3.51
2.73
3.31
2.16
2.36
2.35
2.50
growth rate -72.2% 144.6% -3.4% 35.0% -22.2% 21.3% -34.7% 9.3% -0.4% 6.4%
Leverage 1.30
2.04
1.95
1.81
1.53
1.46
1.36
2.08
1.84
1.46
1.43
growth rate 56.9% -4.4% -7.2% -15.5% -4.6% -6.9% 52.9% -11.5% -20.7% -2.1%
Balance Sheet Dec '07 Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17
Acct.Receivable 207.80
177.50
183.40
228.98
194.40
229.70
258.60
284.19
326.34
362.84
growth rate -14.6% 3.3% 24.9% -15.1% 18.2% 12.6% 9.9% 14.8% 11.2%
Acct.Payable 89.95
27.60
43.70
64.68
65.04
72.09
96.17
growth rate -69.3% 58.3% 48.0% 0.6% 10.8% 33.4%
Cur.Assets 440.60
450.70
496.80
630.61
562.10
536.90
608.76
659.03
735.60
921.36
growth rate 2.3% 10.2% 26.9% -10.9% -4.5% 13.4% 8.3% 11.6% 25.3%
Total Assets 634.90
605.80
628.30
747.48
653.30
636.60
1,033.97
1,041.88
1,102.90
1,303.90
growth rate -4.6% 3.7% 19.0% -12.6% -2.6% 62.4% 0.8% 5.9% 18.2%
Cash 105.10
167.20
182.30
151.24
263.80
199.80
136.37
162.10
216.29
315.80
growth rate 59.1% 9.0% -17.0% 74.4% -24.3% -31.8% 18.9% 33.4% 46.0%
Inventory 122.20
101.60
112.80
105.11
93.90
93.90
157.03
133.25
132.44
182.15
growth rate -16.9% 11.0% -6.8% -10.7% 0.0% 67.2% -15.1% -0.6% 37.5%
Cur.Liabilities 275.30
128.10
140.40
147.86
160.90
124.00
187.07
203.19
231.72
273.49
growth rate -53.5% 9.6% 5.3% 8.8% -22.9% 50.9% 8.6% 14.0% 18.0%
Liabilities 323.40
295.00
280.60
258.93
206.30
169.30
537.09
474.12
350.12
392.04
growth rate -8.8% -4.9% -7.7% -20.3% -17.9% 217.2% -11.7% -26.2% 12.0%
LT Debt 0.00
0.00
128.00
96.00
64.00
0.00
0.00
293.85
218.37
72.00
56.12
growth rate -25.0% -33.3% -100.0% -25.7% -67.0% -22.1%
Equity 439.62
311.50
310.80
347.80
488.55
447.00
467.30
497.65
568.50
753.97
909.58
growth rate -29.1% -0.2% 11.9% 40.5% -8.5% 4.5% 6.5% 14.2% 32.6% 20.6%
Common Shares 33.00
34.00
35.00
36.00
41.00
44.00
43.00
43.00
43.00
46.00
49.00
growth rate 3.0% 2.9% 2.9% 13.9% 7.3% -2.3% 0.0% 0.0% 7.0% 6.5%
Cash Flow Statement Dec '07 Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17
Capital Expenditures 10.38
10.10
3.70
6.70
7.52
9.00
12.98
12.50
19.35
23.55
24.45
growth rate -2.7% -63.4% 81.1% 12.3% 19.6% 44.2% -3.7% 54.8% 21.7% 3.8%
Cash Dividends 0.00
0.00
0.00
0.50
0.00
0.00
0.00
0.00
0.00
0.00
growth rate -100.0%
Cash From OA 8.19
-10.85
53.00
49.10
50.85
22.90
46.00
51.36
89.26
108.46
129.96
growth rate -100.0% 100.0% -7.4% 3.6% -55.0% 100.9% 11.6% 73.8% 21.5% 19.8%
FCF per Share -0.07
-0.66
1.46
1.18
1.15
0.31
0.81
0.67
1.46
1.51
1.41
growth rate 0.0% 100.0% -19.2% -2.5% -73.0% 161.3% -17.3% 117.9% 3.4% -6.6%
Sale Purchase of Stock 92.75
-2.00
-25.80
8.25
9.87
107.39
3.88
growth rate -100.0% 0.0% 100.0% 19.6% 988.1% -96.4%
FCF -2.00
-22.00
50.00
42.00
43.00
13.00
33.00
39.00
70.00
85.00
105.00
growth rate 0.0% 100.0% -16.0% 2.4% -69.8% 153.9% 18.2% 79.5% 21.4% 23.5%
Income Statement Dec '07 Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17
Sales 349.53
429.50
359.30
529.40
551.47
400.70
440.00
582.75
752.52
806.40
900.86
growth rate 22.9% -16.3% 47.3% 4.2% -27.3% 9.8% 32.4% 29.1% 7.2% 11.7%
Op.Income -139.50
-5.10
57.70
45.65
-46.50
39.20
49.64
88.23
113.50
131.52
growth rate 0.0% 100.0% -20.9% -100.0% 100.0% 26.6% 77.7% 28.7% 15.9%
IBT -140.80
-16.20
50.40
53.51
-46.10
46.30
38.68
70.50
95.30
131.98
growth rate 0.0% 100.0% 6.2% -100.0% 100.0% -16.5% 82.3% 35.2% 38.5%
Net Income -135.30
-19.90
34.10
45.65
-45.60
40.00
35.38
56.77
79.44
132.39
growth rate 0.0% 100.0% 33.9% -100.0% 100.0% -11.6% 60.5% 39.9% 66.7%
EPS 0.04
-4.04
-0.58
0.95
1.16
-1.05
0.92
0.83
1.31
1.71
2.71
growth rate -100.0% 0.0% 100.0% 22.1% -100.0% 100.0% -9.8% 57.8% 30.5% 58.5%
Gross Profit 149.88
165.60
139.10
216.50
217.01
159.90
191.50
253.19
339.80
372.41
425.32
growth rate 10.5% -16.0% 55.6% 0.2% -26.3% 19.8% 32.2% 34.2% 9.6% 14.2%
R&D 76.60
64.10
78.30
81.35
71.80
69.60
88.65
103.85
107.10
125.43
growth rate -16.3% 22.2% 3.9% -11.7% -3.1% 27.4% 17.2% 3.1% 17.1%

Quarterly Statements

Item Name Sep '17 Dec '17 Mar '18 Jun '18 Sep '18
Earnings BIT 43.16
40.08
36.88
44.64
37.24
growth rate -7.1% -8.0% 21.1% -16.6%
Balance Sheet Sep '17 Dec '17 Mar '18 Jun '18 Sep '18
Acct.Receivable 385.48
362.84
398.13
375.91
336.65
growth rate -5.9% 9.7% -5.6% -10.4%
Acct.Payable 82.88
96.17
91.93
84.10
81.77
growth rate 16.0% -4.4% -8.5% -2.8%
Cur.Assets 841.21
921.36
951.21
994.06
1,016.65
growth rate 9.5% 3.2% 4.5% 2.3%
Total Assets 1,205.41
1,303.90
1,326.97
1,363.75
1,381.44
growth rate 8.2% 1.8% 2.8% 1.3%
Cash 237.75
315.80
290.06
341.10
383.88
growth rate 32.8% -8.2% 17.6% 12.5%
Inventory 164.05
182.15
198.38
204.86
215.11
growth rate 11.0% 8.9% 3.3% 5.0%
Cur.Liabilities 249.79
273.49
265.49
282.16
261.99
growth rate 9.5% -2.9% 6.3% -7.2%
Liabilities 354.82
392.04
381.67
380.63
362.97
growth rate 10.5% -2.6% -0.3% -4.6%
LT Debt 56.00
56.12
56.23
39.98
40.10
growth rate 0.2% 0.2% -28.9% 0.3%
Equity 848.01
909.58
943.38
981.60
1,017.11
growth rate 7.3% 3.7% 4.1% 3.6%
Common Shares 2.39
2.40
2.41
2.41
2.42
growth rate 0.6% 0.2% 0.1% 0.1%
Cash Flow Statement Sep '17 Dec '17 Mar '18 Jun '18 Sep '18
Capital Expenditures 7.94
4.60
5.88
8.28
5.22
growth rate -42.1% 28.1% 40.7% -36.9%
Cash Dividends
growth rate
Cash From OA 27.78
84.34
-20.45
80.20
52.94
growth rate 203.7% -100.0% 100.0% -34.0%
Sale Purchase of Stock 0.90
1.75
0.68
growth rate 93.8% -60.9%
FCF 19.84
79.75
-26.33
71.92
47.71
growth rate 301.9% -100.0% 100.0% -33.7%
Income Statement Sep '17 Dec '17 Mar '18 Jun '18 Sep '18
Sales 245.66
256.88
250.55
267.52
261.23
growth rate 4.6% -2.5% 6.8% -2.4%
Op.Income 43.16
40.08
36.88
44.64
37.24
growth rate -7.1% -8.0% 21.1% -16.6%
IBT 42.72
42.19
37.57
41.31
34.66
growth rate -1.2% -11.0% 10.0% -16.1%
Net Income 36.55
55.88
30.27
36.12
29.22
growth rate 52.9% -45.8% 19.3% -19.1%
EPS
growth rate
Gross Profit 118.01
121.57
117.91
125.92
120.84
growth rate 3.0% -3.0% 6.8% -4.0%
R&D 31.92
34.77
33.60
34.74
36.36
growth rate 8.9% -3.4% 3.4% 4.7%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

A (87.84)

YOY Growth Grade:

D (48.88)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 21.30 21.30 17.31
EPS / Growth 41.7% 3.09 20.6%

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 16.3%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 16.3% 18.5% 18.5%
Future PE 17.31 25.17 25.17
Future EPS 13.98 16.79 16.79
Value Price
MOS %
59.81
-9.1%
104.45
58.8%
104.45
58.8%
MOS Price 29.90 52.23 52.23
IRT 9.15 8.62 8.62

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.